Systematic review with meta-analysis: Safety and effectiveness of combining biologics and small molecules in inflammatory bowel disease
Crohn's & Colitis 360
Open Access Publication
Rights and Permissions
Quazim A Alayo, MD, Marc Fenster, MD, Osama Altayar, MD, Kerri L Glassner, DO, Ernesto Llano, MD, Kindra Clark-Snustad, DNP, Anish Patel, DO, Lukasz Kwapisz, MD, Andres J Yarur, MD, Benjamin L Cohen, MD, Matthew A Ciorba, MD, Deborah Thomas, MLS, Scott D Lee, MD, Edward V Loftus, Jr., MD, David I Fudman, MD, Bincy P Abraham, MD, Jean-Frederic Colombel, MD, Parakkal Deepak, MD, Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease, Crohn's & Colitis 360, Volume 4, Issue 1, January 2022, otac002, https://doi.org/10.1093/crocol/otac002.© The Author(s) 2022. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Alayo, Quazim A; Altayar, Osama; Ciorba, Matthew A; Thomas, Deborah; Deepak, Parakkal; and et al., "Systematic review with meta-analysis: Safety and effectiveness of combining biologics and small molecules in inflammatory bowel disease." Crohn's & Colitis 360. 4, 1. otac002 (2022).
Supplemental material is available for this article at publisher site.